fcv attenuated vaccine strain f9 (Intervet International GmbH)
Structured Review

Fcv Attenuated Vaccine Strain F9, supplied by Intervet International GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fcv attenuated vaccine strain f9/product/Intervet International GmbH
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Development and Application of a Triplex TaqMan Quantitative Real-Time PCR Assay for Simultaneous Detection of Feline Calicivirus, Feline Parvovirus, and Feline Herpesvirus 1"
Article Title: Development and Application of a Triplex TaqMan Quantitative Real-Time PCR Assay for Simultaneous Detection of Feline Calicivirus, Feline Parvovirus, and Feline Herpesvirus 1
Journal: Frontiers in Veterinary Science
doi: 10.3389/fvets.2021.792322
Figure Legend Snippet: Specificity of the triplex assay. FPV, FCV, FHV-1, and other animal pathogens (including FIV, FeLV, FCoV, RV, and PRV) were selected and tested using the triplex assay. Only FCV, FHV-1, and FPV detected positive.
Techniques Used:
Figure Legend Snippet: Sensitivity of the real-time PCR.
Techniques Used: Real-time Polymerase Chain Reaction
Figure Legend Snippet: Detection limit of conventional PCR. Templates of pMD18T-FPV (A) , pMD18T-FCV-1 (B) , and pMD18T-FHV-1 (C) were diluted by 10 times gradient to a dilution factor that could not be detected by conventional PCR. The detection limit was 5 × 10 3 copies/assay for FPV and 5 × 10 2 copies/assay for FCV and FHV-1. Template amount for curves 2–8 lanes was 5 × 10 7 -5 × 10 1 copies/assay. M, DL600 marker; NC, negative control.
Techniques Used: Marker, Negative Control
Figure Legend Snippet: Amplification and standard curves of the triplex assay. Serially diluted plasmids were mixed at equal concentration (from 5 × 10 7 copies/assay to 5 × 10 1 copies/assay) and used as template for RT-PCR. Amplification curves of the triplex assay for the detection of FPV (A) , FCV (C) , and FHV-1 (E) . The standard curves of FPV (B) , FCV (D) , and FHV-1 (F) were generated by plotting the Ct values (Y-axis) against the logarithm of copy numbers of plasmids (X-axis).
Techniques Used: Amplification, Concentration Assay, Reverse Transcription Polymerase Chain Reaction, Generated
Figure Legend Snippet: Intra- and inter-assay reproducibility of the triplex assay.
Techniques Used: Inter Assay, Intra Assay
Figure Legend Snippet: Detection of the co-infection models by triplex real-time PCR.
Techniques Used: Virus, Real-time Polymerase Chain Reaction
Figure Legend Snippet: Clinical samples detected by triplex assay and commercial kits.
Techniques Used:
Figure Legend Snippet: Specificity of the triplex assay. FPV, FCV, FHV-1, and other animal pathogens (including FIV, FeLV, FCoV, RV, and PRV) were selected and tested using the triplex assay. Only FCV, FHV-1, and FPV detected positive.
Techniques Used:
Figure Legend Snippet: Detection limit of conventional PCR. Templates of pMD18T-FPV (A) , pMD18T-FCV-1 (B) , and pMD18T-FHV-1 (C) were diluted by 10 times gradient to a dilution factor that could not be detected by conventional PCR. The detection limit was 5 × 10 3 copies/assay for FPV and 5 × 10 2 copies/assay for FCV and FHV-1. Template amount for curves 2–8 lanes was 5 × 10 7 -5 × 10 1 copies/assay. M, DL600 marker; NC, negative control.
Techniques Used: Marker, Negative Control
Figure Legend Snippet: Amplification and standard curves of the triplex assay. Serially diluted plasmids were mixed at equal concentration (from 5 × 10 7 copies/assay to 5 × 10 1 copies/assay) and used as template for RT-PCR. Amplification curves of the triplex assay for the detection of FPV (A) , FCV (C) , and FHV-1 (E) . The standard curves of FPV (B) , FCV (D) , and FHV-1 (F) were generated by plotting the Ct values (Y-axis) against the logarithm of copy numbers of plasmids (X-axis).
Techniques Used: Amplification, Concentration Assay, Reverse Transcription Polymerase Chain Reaction, Generated